Kalcipos-D Mite

Colecalciferol, the active ingredient in Kalcipos-D Mite, is a vitamin D supplement presented as a tablet for oral use. It helps correct calcium and vitamin D deficiencies and supports bone health in adults and children. GNH USA supplies Kalcipos-D Mite as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kalcipos-D Mite, containing colecalciferol and calcium, supports mineral metabolism and bone health.

- Calcium deficiency: helps restore normal serum calcium levels. - Vitamin D deficiency: enhances intestinal absorption of calcium and phosphate. - Osteopenia or osteoporosis risk: contributes to bone mineralization and reduces bone loss.

Kalcipos-D Mite may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea or mild gastrointestinal upset. - Constipation or abdominal discomfort. - Mild hypercalcemia presenting as fatigue. - Headache. - Metallic taste.

Serious or Rare Side Effects: - Severe hypercalcemia with symptoms such as polyuria, polydipsia, and cardiac arrhythmia. - Nephrolithiasis (kidney stones). - Allergic reactions including rash, pruritus, or angioedema. - Hypervitaminosis D leading to calcification of soft tissues. - Acute pancreatitis (rare).

Before initiating therapy, consider the following precautions.

- Assess calcium status: check serum calcium and vitamin D levels. - Monitor renal function: avoid use in severe renal impairment. - Review concomitant medications: adjust dose if taking thiazides or lithium. - Pregnancy and lactation: consult a healthcare professional before use. - Hypercalcemia history: contraindicated in patients with known hypercalcemia. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Kalcipos-D Mite can interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Thiazide diuretics: increase risk of hypercalcemia. - Lithium: may exacerbate calcium imbalance. - High‑dose vitamin A supplements: potentiate hypercalcemia.

Moderate Interactions (Monitor Closely): - Corticosteroids: reduce calcium absorption, may require dose adjustment. - Anticonvulsants (e.g., phenytoin, phenobarbital): increase vitamin D metabolism. - Bisphosphonates: concurrent use may require calcium level monitoring. - Loop diuretics: can affect calcium excretion. - Oral calcium supplements: risk of excessive calcium intake.